Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
L156F
-
mutant enzyme shows about 20fold reduced activity and over 70fold reduced activation by the polyamine analogue N1,N11-bis(ethyl)norspermine compared to the wild-type enzyme, expression of the mutant enzymes decreases cellular sensitivity to N1,N11-bis(ethyl)norspermine
E33Q
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
E55Q
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
E74Q
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
E83Q
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
O85E
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
Q53A
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
Y133F
the mutant shows increased enzyme activity compared to the wild type enzyme
E33Q
-
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
-
E55Q
-
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
-
E74Q
-
the mutant shows greatly reduced enzyme activity compared to the wild type enzyme
-
Y133F
-
the mutant shows increased enzyme activity compared to the wild type enzyme
-
E152Q
-
mutation disrupts binding of stabilizing N1,N12-bis(ethyl)spermine to enzyme
E170Stop
-
mutation stabilizes enzyme, due to the lack of ubiquinated complexes
E171Q
-
mutation results in a marked stabilization of enzyme, due to the lack of formation of high-molecular-mass complexes with ubiquitin
E172A
-
mutation stabilizes enzyme, due to the lack of ubiquinated complexes
E173A
-
mutation stabilizes enzyme, due to the lack of ubiquinated complexes
K111R
-
mutant with the same activity as wild-type enzyme, but reduced half-life
K141R
-
mutant with 35% of activity of wild-type enzyme, increased Km for spermidine and reduced half-life
K158R
-
mutant with 139% of activity of wild-type enzyme
K161R
-
mutant with the same activity as wild-type enzyme
K166R
-
mutant with 78% of activity of wild-type enzyme
K22R
-
mutant with 149% of activity of wild-type enzyme, but reduced half-life
K26R
-
mutant with 120% of activity of wild-type enzyme
K39R
-
mutant with the same activity as wild-type enzyme
K3R
-
mutant with 134% of activity of wild-type enzyme
K61R
-
mutant with the same activity as wild-type enzyme
K87R
-
mutant with 70% of activity of wild-type enzyme, but significantly longer half-life, suggesting that Lys-87 may be the preferred site for ubiquination
R101K
site-directed mutagenesis of SSAT1 protein, ability to promote hypoxia-inducible factor-1 (HIF-1alpha) degradation reduced
S82D/T83A
-
inactive mutant
D93N
site-directed mutagenesis, the mutation affects both substrate binding and catalysis without changing the pH dependence of the enzyme
E92Q
site-directed mutagenesis, the mutation has a detrimental effect on both substrate binding and catalysis and shifts the optimal pH for enzyme activity further into alkaline solution conditions
K87R
-
the mutant has a longer half-life than wild type or any of the other mutants
additional information
construction of a chimeric gene named ssat1a248b, as it contains nucleotides 1-248 of ssat1a and the remainder of ssat1b. Chimeric genes ssat1a332b, ssat1a374b, ssat1a453b, ssat1b248a, ssat1b332a, ssat1b389a, and ssat1b467a are also prepared in this manner
additional information
-
construction of a chimeric gene named ssat1a248b, as it contains nucleotides 1-248 of ssat1a and the remainder of ssat1b. Chimeric genes ssat1a332b, ssat1a374b, ssat1a453b, ssat1b248a, ssat1b332a, ssat1b389a, and ssat1b467a are also prepared in this manner
additional information
-
18 promoter polymorphisms of SAT1 are identified in French-Canadian population, haplotypes and genotyping, overview
additional information
-
transgenic overexpression of SSAT protects from kainate and epilepsy-like seizure activity induction by pentylenetetrazol
additional information
knockdown of enzyme SSAT1 in Hep-G2 cells and in primary hepatocytes
additional information
-
knockdown of enzyme SSAT1 in Hep-G2 cells and in primary hepatocytes
additional information
small interfering RNAs (siRNAs) against SSAT-1 are transfected weekly in rheumatoid arthritis synovial fibroblasts
additional information
-
small interfering RNAs (siRNAs) against SSAT-1 are transfected weekly in rheumatoid arthritis synovial fibroblasts
additional information
-
crossing of ApcMin/+ MIN mice with enzyme-overexpressing transgenic mice results in mice with a 3-6fold higher development of adenomas in the small intestine and colon compared to wild-type mice, crossing of ApcMin/+ MIN mice with SSAT-knockout mice reduces the development of adenomas by 75% in the small intestine
additional information
-
enzyme overexpression in transgenic mice leads to accumulation of purtrescine and permanent hair loss at the age of 3-weeks, because the hair follicles are exchanged for dermal cysts and epidermal utriculi due to reduced expression of terminal differentiation markers such as cytokeratins 1/10, and filaggrin, and persisting expression of basal cell cytokeratins 5/14 in the suprabasal layer, hair growth can be reactivated by reduction of putrescine content
additional information
-
construction of SSAT-deficient fetal fibroblasts transiently expressing an SSAT-EGFP construct
additional information
-
mice, which have a ubiquitous SSAT overexpression due to an increase in the Sat1 gene copy number, have decreased tumor incidence in the skin in response to a two-stage tumorigenesis protocol. Pleiotropic effects of the changes associated with widespread high levels of SSAT expression in transgenic mice with increased Sat1 gene copies. Phenotype of SSAT knockout mice, overview